Asbestos and disease genomics : is mesothelioma a genomic paradigm?
Jaurand, Marie-Claude and Murphy, Fiona and Felley-Bosco, Emanuela (2025) Asbestos and disease genomics : is mesothelioma a genomic paradigm? Frontiers in Toxicology, 6. 1536344. ISSN 2673-3080 (https://doi.org/10.3389/ftox.2024.1536344)
Preview |
Text.
Filename: Jaurand-etal-2025-ftox-Asbestos-and-disease-genomics-is-mesothelioma-a-genomic-paradigm.pdf
Final Published Version License:
Download (624kB)| Preview |
Abstract
A paradigm is a set of assumptions that creates a viewpoint of the world. However, as summarized by Carlo Rovelli (Carlo Rovelli, 2016), “scientific knowledge is the process of continuously modifying and improving our conception of the world, selectively and constantly questioning the assumptions on which it is based.” In this Editorial, we aim to challenge the current assumptions surrounding the concept of mesothelioma as a genomic disease through a comprehensive review of our understanding of disease pathogenesis and integration of recent findings reported in this Research Topic (Leinardi et al.; Sekido and Sato; Farahmand et al.; Fisher et al.).
ORCID iDs
Jaurand, Marie-Claude, Murphy, Fiona
ORCID: https://orcid.org/0000-0001-7925-0632 and Felley-Bosco, Emanuela;
-
-
Item type: Article ID code: 91833 Dates: DateEvent3 January 2025Published5 December 2024Accepted28 November 2024SubmittedSubjects: Medicine > Biomedical engineering. Electronics. Instrumentation
Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 20 Jan 2025 11:58 Last modified: 07 Jan 2026 09:52 URI: https://strathprints.strath.ac.uk/id/eprint/91833
Tools
Tools






